Multivalent metal salts of boronic acids
First Claim
Patent Images
1. A salt of a pharmaceutically acceptable multivalent metal and an organoboronic acid inhibitor of thrombin having a neutral thrombin S1-binding moiety linked to a hydrophobic thrombin S2/S3-binding moiety.
5 Assignments
0 Petitions
Accused Products
Abstract
Salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug. Examples of such metals are calcium, magnesium and zinc. The organoboronic acid drug may be a boropeptide protease inhibitor. The salts may be formulated in oral dosage form.
43 Citations
27 Claims
- 1. A salt of a pharmaceutically acceptable multivalent metal and an organoboronic acid inhibitor of thrombin having a neutral thrombin S1-binding moiety linked to a hydrophobic thrombin S2/S3-binding moiety.
- 12. A salt of a pharmaceutically acceptable multivalent metal and a peptide boronic acid of formula (IV):
-
21. A pharmaceutical formulation adapted for oral administration and comprising
a) a first species selected from a boronic acid of formula (III), and boronate ions of said boronic acid and equilibrium forms of said boronic acid and said boronate ions: -
wherein
Y comprises a moiety which, together with the aminoboronic acid residue —
NHCH(R9)—
B(OH)2, has affinity for the substrate binding site of thrombin; and
R9 is a straight chain alkyl group interrupted by one or more ether linkages and in which the total number of oxygen and carbon atoms is 3, 4, 5 or 6 or R9 is —
(CH2)m-W where m is from 2, 3, 4 or 5 and W is —
OH or halogen; and
(b) a second species selected from multivalent metal ions having a valency n, wherein the formulation has an observed stoichiometry of first to second species essentially consistent with a notional stoichiometry of n;
1.
-
-
24. A medicament adapted for oral administration and comprising a therapeutically effective amount of a multivalent metal salt of a boronic acid which is a selective thrombin inhibitor and has a neutral aminoboronic acid residue capable of binding to the thrombin S1 subsite linked through a peptide linkage to a hydrophobic moiety capable of binding to the thrombin S2 and S3 subsites, the salt comprising a cation having a valency n and having an observed stoichiometry consistent with a notional stoichiometry (boronic acid:
- cation) of n;
1. - View Dependent Claims (25, 26)
- cation) of n;
Specification